4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-23-018505
Options or other derivatives
- EVP, Strategy & Innovation acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-23-018505
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…